{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:34:46Z","timestamp":1769312086410,"version":"3.49.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Corp.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229393","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:51:28Z","timestamp":1582293088000},"page":"e0229393","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections"],"prefix":"10.1371","volume":"15","author":[{"given":"Ying P.","family":"Tabak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latha","family":"Vankeepuram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-9390","authenticated-orcid":true,"given":"Eilish","family":"McCann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"issue":"4","key":"pone.0229393.ref001","first-page":"1","article-title":"Deaths: final data for 2014","volume":"65","author":"KD Kochanek","year":"2016","journal-title":"Natl Vital Stat Rep"},{"key":"pone.0229393.ref002","unstructured":"Torio CM, Moore BJ. National inpatient hospital costs: the most expensive conditions by payer, 2013 (HCUP Statistical Brief #204). May 2016 [cited 20 November 2017]. Available from: https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb204-Most-Expensive-Hospital-Conditions.jsp"},{"key":"pone.0229393.ref003","unstructured":"Pfuntner A, Wier LM, Stocks C. Statistical Brief #162: most frequent conditions in U.S. hospitals, 2011. September 2013 [cited 2 October 2017]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK169248\/pdf\/Bookshelf_NBK169248.pdf"},{"issue":"9","key":"pone.0229393.ref004","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3201\/eid2209.150680","article-title":"Trends in pneumonia mortality rates and hospitalizations by organism, United States, 2002\u20132011","volume":"22","author":"BA Wuerth","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 1","key":"pone.0229393.ref005","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/653053","article-title":"Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"51","author":"RN Jones","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pone.0229393.ref006","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jiph.2016.11.016","article-title":"Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit","volume":"10","author":"ZM Djordjevic","year":"2017","journal-title":"J Infect Public Health"},{"issue":"Suppl 2","key":"pone.0229393.ref007","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"LA Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0229393.ref008","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"AC Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"pone.0229393.ref009","unstructured":"Antimicrobial Resistance Global Report on Surveillance. June 2014 [cited 2 October 2017]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/112642\/1\/9789241564748_eng.pdf?ua=1"},{"key":"pone.0229393.ref010","unstructured":"Untreatable: Report by CDC details today\u2019s drug-resistant health threats. September 2013 [cited 2 October 2017]. Available from: https:\/\/www.cdc.gov\/media\/releases\/2013\/p0916-untreatable.html"},{"issue":"8","key":"pone.0229393.ref011","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/677157","article-title":"Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States","volume":"35","author":"JT Thaden","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"pone.0229393.ref012","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijantimicag.2014.01.007","article-title":"Antimicrobial susceptibility of gram-negative organisms isolated from patients hospitalised with pneumonia in U.S. and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009\u20132012","volume":"43","author":"HS Sader","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"pone.0229393.ref013","doi-asserted-by":"crossref","first-page":"e0143845","DOI":"10.1371\/journal.pone.0143845","article-title":"Outcomes and risk factors for mortality among patients treated with carbapenems for Klebsiella spp. bacteremia","volume":"10","author":"LR Biehle","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"pone.0229393.ref014","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/jac\/dkw590","article-title":"on behalf of CARBAFEST Group. Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceae in North-Eastern France and outcomes of infected patients","volume":"72","author":"A Muggeo","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"pone.0229393.ref015","doi-asserted-by":"crossref","first-page":"32665","DOI":"10.1038\/srep32665","article-title":"High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae","volume":"6","author":"PF Wu","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0229393.ref016","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12879-017-2383-z","article-title":"Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis","volume":"17","author":"MD Zilberberg","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"4","key":"pone.0229393.ref017","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/cid\/cix379","article-title":"The effect of a piperacillin\/tazobactam shortage on antimicrobial prescribing and Clostridium difficile risk in 88 US medical centers","volume":"65","author":"AE Gross","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pone.0229393.ref018","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/670621","article-title":"Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study","volume":"34","author":"YP Tabak","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"pone.0229393.ref019","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1086\/660360","article-title":"sing electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals","volume":"32","author":"MD Zilberberg","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"pone.0229393.ref020","unstructured":"Clinical Classifications Software (CCS) for ICD-9-CM. March 2017 [cited 26 September 2017]. Available from: https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccs\/ccs.jsp"},{"issue":"13","key":"pone.0229393.ref021","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/amiajnl-2013-001790","article-title":"Using electronic health record data to develop inpatient mortality predictive model: Acute Laboratory Risk of Mortality Score (ALaRMS)","volume":"21","author":"YP Tabak","year":"2014","journal-title":"J Am Med Inform Assoc"},{"key":"pone.0229393.ref022","unstructured":"Parsons LS. Reducing bias in a propensity score matched-pair sample using Greedy matching techniques. Presented at the Twenty-Sixth Annual SAS Users Group International Conference. 2001: Paper 214\u201326."},{"issue":"7","key":"pone.0229393.ref023","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"ffect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"B Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"pone.0229393.ref024","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1128\/AAC.01359-16","article-title":"Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014","volume":"60","author":"LF Mataseje","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pone.0229393.ref025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archinternmed.2009.509","article-title":"Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia","volume":"170","author":"MR Eber","year":"2010","journal-title":"Arch Intern Med"},{"issue":"3","key":"pone.0229393.ref026","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/664049","article-title":"Economic impact of ventilator-associated pneumonia in a large matched cohort","volume":"33","author":"MH Kollef","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"22","key":"pone.0229393.ref027","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","article-title":"Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system","volume":"173","author":"E Zimlichman","year":"2013","journal-title":"JAMA Intern Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:51:45Z","timestamp":1582293105000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229393"}},"subtitle":[],"editor":[{"given":"Gabriel A.","family":"Picone","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229393","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]}}}